thcfreecbd.shop

UK Laws (Overview) — THC‑Free CBD 2025

This overview summarizes common UK considerations for CBD marketed as “THC‑free.” It is not legal advice. Policies and enforcement evolve; verify with UK government sources, the Food Standards Agency (FSA), Home Office, local Trading Standards, and current Novel Foods lists.

Snapshot

  • Product‑type specific: Rules differ for foods/food supplements, cosmetics/topicals, vapes/e‑liquids, and other formats.
  • Novel Foods: Ingestible CBD products typically require valid linkage to an FSA Novel Foods application and appearance on the appropriate status list to be lawfully marketed in Great Britain.
  • Controlled cannabinoids: THC and some related substances are controlled drugs. “THC‑free” is not a legal category; it’s a lab reporting outcome (e.g., ND at LOQ). Compliance must still consider controlled‑substances law.

Product categories at a glance

  • Foods/food supplements: Novel Foods requirements apply; businesses should ensure their SKUs are linked to validated applications. Labels must not carry medicinal claims.
  • Cosmetics/topicals: Must comply with UK cosmetics rules (safety assessment, ingredient restrictions, labeling). If positioned as a cosmetic, avoid medicinal claims.
  • Vapes/e‑liquids: Non‑nicotine CBD vapes fall under general product safety rules and relevant trading standards oversight; nicotine rules (TRPR) do not automatically apply if there is no nicotine.

The “1 mg per container” point

Guidance referencing a limit of no more than 1 mg of controlled cannabinoids per container is often cited in UK discussions. This is not a blanket authorization to include controlled drugs; it reflects enforcement considerations and analytical realities. Businesses should seek competent legal advice and ensure products do not contain controlled substances above de minimis levels when measured using appropriate methods.

Labeling, testing, and “THC‑free”

  • “THC‑free” should be supported by batch‑level COAs showing Δ9‑THC (and ideally THCA) as Not Detected (ND) at a clearly stated LOQ. See LOQ vs LOD.
  • Ensure accuracy of cannabinoid content claims (CBD mg per serving/container) and avoid medicinal claims. Keep batch/lot traceability.

Advertising and claims

  • Follow ASA/CAP guidance on advertising; avoid disease and medicinal claims. Take care with testimonials and implied outcomes.
  • Online listings and social media content are in scope for enforcement.

Import, export, and distance sales

  • Import/export: Controlled‑substance thresholds and documentation may apply depending on ingredients and measured cannabinoids. Seek qualified counsel before cross‑border moves.
  • Distance sales: UK sellers shipping abroad must meet destination rules; overseas sellers shipping to the UK must meet UK rules.

Travel

  • Domestic travel generally focuses on possession of lawful consumer goods; carry original packaging and proof of purchase.
  • International travel with CBD is risky due to jurisdictional differences. See International Travel Guidelines.

How to verify quickly

  1. Confirm product type (food, cosmetic, vape) and the applicable regulatory route (e.g., Novel Foods).
  2. Match batch codes to recent COAs; confirm accredited lab, method, and LOQ.
  3. Check labels and websites for claims and required consumer information; avoid medicinal positioning.

FAQ

Is “THC‑free” a legal category in the UK?
No. It is a test outcome. Controlled‑substance law and product‑type rules still apply.
Can I sell CBD foods without Novel Foods authorization?
Generally no. Products typically must be linked to a valid Novel Foods application and comply with FSA expectations.
What does the “1 mg per container” point mean?
It reflects enforcement and analytical context, not a free allowance to include controlled drugs. Seek legal advice.

Related resources

Contextual CTA: If you decide to shop, verify Novel Foods status (where relevant) and COAs. See Cannagea — THC‑Free for examples of THC‑free formulations.